Default company panoramic image


Innovative approach to dermatology drug development using re-profiled drugs to treat various skins diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Conway, AR, USA
  • Currency USD
  • Website

Company Summary

SWITCHBIOTECH uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders. By using proprietary technology we can rapidly profile potential new and re-profile existing compounds for possible treatments for a variety of diseases. Therapeutic areas of interest include -- Psoriasis, Atopic Dermatitis, Vitiligo, Androgenic Alopecia and other non-dermatologic areas.


Previous Investors

  • Default avatar
    100 percent owner financed